Mendoza-Popoca CÚ, Suárez-Morales M

Language: Spanish
References: 8
Page: 153-155
PDF size: 149.57 Kb.

REFERENCES

1. Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360:765-773.

2. Lasocki A, Gaillard F. Non-contrast-enhancing tumor: a new frontier in glioblastoma research. Am J Neuroradiol. 2019;40:758-765.

3. Mabray MC, Barajas RF, Soomee C. Modern brain tumor imaging. Brain Tumor Res Treat. 2015;3:8-23.

4. Revilla F, Rodriguez P, Barrera M, et al. Extent of resection and survival in patients with glioblastoma multiforme. Systemic review and meta-analysis. Medicine. 2021;100:25.

5. Molinaro AM, Hervey -Jumper S, Morshed RA, et al. Association of maximal extent of resection of contrast-enhaced and no-contrast-enhaced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol. 2020;6:495-503.

6. Ruis C, Huenges I, Robe P, et al. Anxiety in the preoperative phase of awake brain tumor surgery. Clin Neurol Neurosurg. 2017;157:7-10.

7. Takami H, Khoshnood N, Bernstaein M. Preoperative factors associated with adverse events during awake craniotomy: analysis of 609 consecutive cases. J Neurosurg. 2021;134:1631-1639.

8. Milian M, Luerding R, Ploppa A, Decker K, et al. "Imagine your neighbor mows the lawn": a pilot study of psychological sequelae due to awake craniotomy. J Neurosurg. 2013;118:1288-1295.